Retraction

The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC

Paper Information

Record ID:
40408
Publication Date:
July 15, 2018
Retraction Date:
November 08, 2022 (3.0 years years ago)
Article Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (58)

58
Total Citations
5
Post-Retraction
(8.6%)
53
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
2 Within 1 year
0 After 2+ years
540 Days since retraction (latest)
Downregulation of lncRNA MIR17HG reduced tumorigenicity and Treg‐mediated immune escape of non‐small‐cell lung cancer cells through targeting the miR‐17‐5p/RUNX3 axis
Guanghua Zheng, Hui Ye, Junjun Bai et al. (4 authors)
Journal of Biochemical and Molecular Toxicology
Published: May 2024
5 citations
540 days after retraction
Emerging role of competing endogenous RNA in lung cancer drug resistance
Shijie Wu, Ting Luo, Xiaoyong Lei et al. (4 authors)
Journal of Chemotherapy
Published: Dec 2023
407 days after retraction
Long non-coding RNA and Evolving drug resistance in lung cancer
Meibin Wang, Yujie Fu, Chuyue Zhong et al. (5 authors)
Heliyon Open Access
Published: Nov 2023
9 citations
381 days after retraction
The expression analysis of long non-coding RNAs and p53 as a possible genetic signature in luminal: An invasive breast ductal carcinoma
Farkhondeh Pouresmaeili, Nahal Eshghifar, Fatemeh Rouhollah et al. (5 authors)
Journal of Cancer Prevention & Current Research
Published: Feb 2023
94 days after retraction
Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
Binfeng Liu, Ke Pang, Chengyao Feng et al. (10 authors)
Frontiers in Genetics Open Access
Published: Dec 2022
13 citations
29 days after retraction
Role of Non-Coding RNAs in Lung Cancer
Maksat Babayev, Patricia Silveyra
IntechOpen eBooks Open Access
Published: Oct 2022
1 citation
20 days before retraction
Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer
Jingwei Li, Peiyi Li, Jun Shao et al. (9 authors)
Cancers Open Access
Published: Sep 2022
11 citations
57 days before retraction
Long non-coding RNA OGFRP1 regulates cell proliferation and ferroptosis by miR-299-3p/SLC38A1 axis in lung cancer
Liang Liu, Shengtian Su, Dan Ye et al. (6 authors)
Anti-Cancer Drugs
Published: Aug 2022
20 citations
69 days before retraction
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia et al. (9 authors)
Frontiers in Oncology Open Access
Published: Aug 2022
84 citations
83 days before retraction
miR-150-3p enhances neuroprotective effects of neural stem cell exosomes after hypoxic-ischemic brain injury by targeting CASP2
Hongcheng Luo, Guangbin Ye, Yu Liu et al. (7 authors)
Neuroscience Letters Open Access
Published: Apr 2022
45 citations
207 days before retraction
MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
Amirhosein Maharati, Amir Sadra Zanguei, Ghazaleh Khalili‐Tanha et al. (4 authors)
Cell Communication and Signaling Open Access
Published: Mar 2022
18 citations
244 days before retraction
<scp>miR‐129‐2</scp> upregulation induces apoptosis and promotes <scp>NSCLC</scp> chemosensitivity by targeting <scp>SOX4</scp>
Weizheng Zhou, Chengliang Cai, Jie Lu et al. (4 authors)
Thoracic Cancer Open Access
Published: Feb 2022
6 citations
270 days before retraction
Construction of a Nomogram Based on lncRNA and Patient’s Clinical Characteristics to Improve the Prognosis of Non-Small Cell Lung Cancer
Helin Wang, Mingying Li, Ying Wang et al. (4 authors)
Technology in Cancer Research & Treatment Open Access
Published: Jan 2022
3 citations
311 days before retraction
Epigenetics and precision medicine in lung cancer
Alejandro Cardona-Monzonís, Ángel Ortega, Julián Carretero et al. (5 authors)
Elsevier eBooks
Published: Nov 2021
1 citation
354 days before retraction
Identification of lncRNA–miRNA–mRNA Networks Linked to Non-small Lung Cancer Resistance to Inhibitors of Epidermal Growth Factor Receptor
Ting Wang, Chengliang Yang, Bing Li et al. (8 authors)
Frontiers in Genetics Open Access
Published: Nov 2021
7 citations
361 days before retraction
FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop
Zhongxing Bing, Jiashu Han, Zhibo Zheng et al. (4 authors)
Life Sciences
Published: Oct 2021
22 citations
399 days before retraction
RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑6884‑5p thus releasing TOP2A mRNA
Shoubin Cui, Fengling Li
Oncology Reports Open Access
Published: Aug 2021
8 citations
447 days before retraction
Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma
Yujie Feng, Xiao Hu, Kai Ma et al. (5 authors)
BioMed Research International Open Access
Published: May 2021
17 citations
537 days before retraction
LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis
Ge Peng, Lei Cao, Ming Zheng et al. (6 authors)
Experimental and Molecular Pathology
Published: Mar 2021
35 citations
599 days before retraction
Gefitinib reduces oocyte quality by disturbing meiotic progression
Hongyong Zhang, Ying‐Chun Ouyang, Jian Li et al. (9 authors)
Toxicology
Published: Feb 2021
7 citations
641 days before retraction
LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis
Jinlan Guo, Quan Gan, Caibin Gan et al. (6 authors)
Aging Open Access
Published: Feb 2021
23 citations
645 days before retraction
LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
Jie Wu, Chunlei Zheng, Yizhe Wang et al. (14 authors)
Biomarker Research Open Access
Published: Jan 2021
38 citations
647 days before retraction
Peer Review #1 of "Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma (v0.1)"
Wanzhen Li, Shiqing Liu, Shihong Su et al. (5 authors)
Unknown Journal Open Access
Published: Jan 2021
669 days before retraction
Peer Review #3 of "Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma (v0.1)"
Wanzhen Li, Shiqing Liu, Shihong Su et al. (5 authors)
Unknown Journal Open Access
Published: Jan 2021
669 days before retraction
Peer Review #2 of "Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma (v0.1)"
Alexander Tonevitsky
Unknown Journal Open Access
Published: Jan 2021
669 days before retraction
Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
Wanzhen Li, Shiqing Liu, Shihong Su et al. (5 authors)
PeerJ Open Access
Published: Jan 2021
4 citations
669 days before retraction
miR-150-3p Enhances Neuroprotective Effects of Neural Stem Cell Exosomes after Hypoxic-Ischemic Brain Injury by Targeting CASP2
Hongcheng Luo, Guangbin Ye, Yu Liu et al. (7 authors)
SSRN Electronic Journal
Published: Jan 2021
676 days before retraction
Overexpression of CTEN is associated with gefitinib resistance in non‑small cell lung cancer
Xiangdong Lu, Yao Zhang, Yukai Pan et al. (6 authors)
Oncology Letters Open Access
Published: Nov 2020
7 citations
725 days before retraction
Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
Zhenyao Chen, Qinnan Chen, Zhixiang Cheng et al. (10 authors)
Cell Death and Disease Open Access
Published: Oct 2020
86 citations
755 days before retraction
New insights into long non-coding RNAs in non-small cell lung cancer
Ruifang Ye, Ruixiang Tang, Siyuan Gan et al. (8 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Sep 2020
41 citations
773 days before retraction
Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients
Jiarong Cai, Zheng Chen, Xuelian Chen et al. (6 authors)
BioMed Research International Open Access
Published: Sep 2020
14 citations
798 days before retraction
The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer
Hao Zhou, Bing Feng, Mubalake Abudoureyimu et al. (9 authors)
Life Sciences Open Access
Published: Aug 2020
28 citations
801 days before retraction
Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer
Manuela La Montagna, L. H. GINN, Michela Garofalo
Cancer Gene Therapy Open Access
Published: Aug 2020
25 citations
805 days before retraction
Prognostic potential of lncRNA RHPN1-AS1 in glioma
Yong Wu, Wuting Wei, Linjun Tang et al. (4 authors)
Oncology Letters Open Access
Published: Jun 2020
1 citation
866 days before retraction
&lt;p&gt;lncRNA RHPN1-AS1 Promotes Ovarian Cancer Growth and Invasiveness Through Inhibiting miR-1299&lt;/p&gt;
Lin Zhao, Ting Liu, Xingna Zhang et al. (5 authors)
OncoTargets and Therapy Open Access
Published: Jun 2020
20 citations
890 days before retraction
RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer
Juan Zhao, Ting Yang, Jing Ji et al. (6 authors)
Cancer Gene Therapy
Published: May 2020
24 citations
896 days before retraction
LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma
Wei Zhang, Lei Han, Xing Peng et al. (7 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: May 2020
10 citations
901 days before retraction
Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer
Jingjing Shi, Yutang Huang, Chunjie Wen et al. (6 authors)
Computational Biology and Chemistry
Published: May 2020
5 citations
903 days before retraction
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1
Junrong Wang, Weimin Ding, Yingke Xu et al. (10 authors)
Aging Open Access
Published: Mar 2020
89 citations
971 days before retraction
Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis
Wei Zheng, Hui Li, Hui Zhang et al. (7 authors)
Cancer Cell International Open Access
Published: Feb 2020
30 citations
994 days before retraction
STAT1‐induced upregulation of lncRNA RHPN1‐AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR‐485/CDCA5 axis
Xiaozhan Zhang, Zhenzhen Yan, Lei Wang et al. (5 authors)
Journal of Cellular Biochemistry
Published: Feb 2020
20 citations
995 days before retraction
<i>Retracted</i>: Long noncoding RNA RHPN1‐AS1, induced by KDM5B, is involved in breast cancer via sponging miR‐6884‐5p
Liang Dong, Hui Liu, Qinheng Yang et al. (7 authors)
Journal of Cellular Biochemistry Open Access
Published: Jan 2020
7 citations
1012 days before retraction
LncRNA NEAT1 exacerbates non-small cell lung cancer by upregulating EIF4G2 via miR-582-5p sponging
Xin Zhang, Zhonghua Sun, Yuepei Zou
Archives of Biological Sciences Open Access
Published: Jan 2020
2 citations
1042 days before retraction
RETRACTED: LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
Xuezhen Song, Xiao-ning Ren, Xiaojun Xu et al. (6 authors)
Technology in Cancer Research & Treatment Open Access
Published: Jan 2020
23 citations
1042 days before retraction
Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application
Yuan-Xiang Shi, Deqiao Sheng, Lin Cheng et al. (4 authors)
Journal of Oncology Open Access
Published: Dec 2019
52 citations
1062 days before retraction
Long non-coding RNA in lung cancer
Zhenyao Chen, Tianyao Lei, Xin Chen et al. (7 authors)
Clinica Chimica Acta
Published: Nov 2019
63 citations
1075 days before retraction
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis
Fen Hu, Zheng Hongmin, Wei Wei et al. (7 authors)
Current Pharmaceutical Design
Published: Nov 2019
34 citations
1099 days before retraction
LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299–3p/FGF2 axis
Haixia Duan, Xiaojuan Li, Youyi Chen et al. (5 authors)
Life Sciences
Published: Sep 2019
45 citations
1152 days before retraction
Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma
Zekai Huang, Yuanyuan Ma, Panpan Zhang et al. (6 authors)
Anti-Cancer Drugs
Published: Sep 2019
24 citations
1155 days before retraction
Quick Stats
Total Citations: 58
Years Since Retraction: 3.0 years
Open Access: Yes
Last Checked: Jul 24, 2025